MAGELLAN HEALTH INC·4

Jan 4, 12:45 PM ET

Rubin Jonathan N 4

4 · MAGELLAN HEALTH INC · Filed Jan 4, 2018

Insider Transaction Report

Form 4
Period: 2018-01-03
Rubin Jonathan N
Chief Financial Officer
Transactions
  • Exercise of In-Money

    Ordinary Common Stock, $0.01 par value

    2018-01-03$53.72/sh+30,086$1,616,22056,533 total
  • Sale

    Ordinary Common Stock, $0.01 par value

    2018-01-03$96.16/sh30,086$2,893,02826,447 total
  • Exercise of In-Money

    Stock Options (right to buy)

    2018-01-0330,08623,764 total
    Exercise: $53.72Exp: 2025-11-02Common Stock (30,086 underlying)
Footnotes (4)
  • [F1]This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
  • [F2]The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $94.35 to $97.35, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
  • [F3]The remainder of 23,764 options shall vest on November 2, 2018.
  • [F4]Not applicable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION